BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8788493)

  • 1. Novel discriminatory ligands for 5-HT2B receptors.
    Baxter GS
    Behav Brain Res; 1996; 73(1-2):149-52. PubMed ID: 8788493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
    Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2 receptor subtypes: a family re-united?
    Baxter G; Kennett G; Blaney F; Blackburn T
    Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin.
    Choi DS; Colas JF; Kellermann O; Loric S; Launay JM; Rosay P; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):403-11. PubMed ID: 7920184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of human 5-HT2 receptor subtypes.
    Jerman JC; Brough SJ; Gager T; Wood M; Coldwell MC; Smart D; Middlemiss DN
    Eur J Pharmacol; 2001 Feb; 414(1):23-30. PubMed ID: 11230991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?
    Kalkman HO
    Life Sci; 1994; 54(10):641-4. PubMed ID: 8107508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
    Siegel BW; Freedman J; Vaal MJ; Baron BM
    Eur J Pharmacol; 1996 Feb; 296(3):307-18. PubMed ID: 8904083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist.
    Bonhaus DW; Weinhardt KK; Taylor M; DeSouza A; McNeeley PM; Szczepanski K; Fontana DJ; Trinh J; Rocha CL; Dawson MW; Flippin LA; Eglen RM
    Neuropharmacology; 1997; 36(4-5):621-9. PubMed ID: 9225287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
    Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
    Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle.
    Baxter GS; Murphy OE; Blackburn TP
    Br J Pharmacol; 1994 May; 112(1):323-31. PubMed ID: 8032658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; PrzegaliƄski E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk inhibition between 5-HT
    Perim RR; Fields DP; Mitchell GS
    Am J Physiol Regul Integr Comp Physiol; 2018 May; 314(5):R709-R715. PubMed ID: 29384698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells.
    Choi DS; Ward SJ; Messaddeq N; Launay JM; Maroteaux L
    Development; 1997 May; 124(9):1745-55. PubMed ID: 9165122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.